News Daily News Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE Michael O'Riordan November 24, 2025
News Daily News CVD Still the Leading Cause of Death and Disease Globally Michael O'Riordan September 24, 2025
News Daily News Gut Microbes Linked to Risk of Abdominal Aortic Aneurysms Michael O'Riordan August 20, 2025
News Daily News Take Heed of Sex Differences in Peripheral Vascular Disease: AHA Michael O'Riordan March 13, 2025
News Daily News Coverage and Use of Impella and Watchman: A Tale of Four Countries Michael O'Riordan March 04, 2025
News Daily News AHA Stats Show CV Health of Americans Remains Dire Michael O'Riordan January 28, 2025
News Daily News Just One in Five Grand Rounds Lectures Given by Women Michael O'Riordan January 07, 2025
News Daily News New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery Michael O'Riordan September 24, 2024
News Daily News Little Pre- and Postmarket Testing for Most Recalled CV Devices Michael O'Riordan September 16, 2024
News Daily News AAA-Related Mortality Rates Decline, With Reductions Seen in All Groups Michael O'Riordan July 29, 2024
News Daily News Physicians (Mostly) Negative on Private Equity in Healthcare Michael O'Riordan March 13, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024
News Daily News BP Reductions Last 5 Years After Bariatric Surgery: GATEWAY Michael O'Riordan February 07, 2024
News Daily News Experts Warn of Looming Private Equity Interest in Cardiology Care Michael O'Riordan January 15, 2024
News Daily News AHA Throws Its Support Behind New, Independent Medical Board Michael O'Riordan October 30, 2023
News Daily News BP Reduction With Renal Denervation Still Evident a Decade On Michael O'Riordan January 31, 2023
News Daily News Medical Devices Cleared on Faulty Predicates More Likely to be Recalled Michael O'Riordan January 17, 2023
News Daily News Reduction in BP Drives Treatment Preference for Hypertensive Patients Michael O'Riordan December 20, 2022